Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jutta Deininger"'
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Table 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5834d0b437588e31e30c2b7b2f8cb03c
https://doi.org/10.1158/0008-5472.22366581
https://doi.org/10.1158/0008-5472.22366581
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
The JAK2V617F mutation is present in almost all patients with polycythemia vera (PV), large proportions of patients with essential thrombocythemia and idiopathic myelofibrosis, and less frequently in atypical myeloproliferative disorders (MPD). We sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c69384adb1bdd7aaf4555863bbaec04
https://doi.org/10.1158/0008-5472.c.6495210.v1
https://doi.org/10.1158/0008-5472.c.6495210.v1
Supplementary Figure 3 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Figure 3 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9791662320c50b8f97c05efed32ba0b6
https://doi.org/10.1158/0008-5472.22366593
https://doi.org/10.1158/0008-5472.22366593
Supplementary Figure 4 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Figure 4 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b90bf32cd4f5eb64b72072a51805993
https://doi.org/10.1158/0008-5472.22366590.v1
https://doi.org/10.1158/0008-5472.22366590.v1
Supplementary Figure 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Figure 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73149219dcf6e94dd37366db1f87e45c
https://doi.org/10.1158/0008-5472.22366602.v1
https://doi.org/10.1158/0008-5472.22366602.v1
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Methods and Materials from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a42176fc978b286b16793a15b43a024
https://doi.org/10.1158/0008-5472.22366584
https://doi.org/10.1158/0008-5472.22366584
Supplementary Figure 5 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Figure 5 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989bde32ba98051becd491a7a7296be2
https://doi.org/10.1158/0008-5472.22366587.v1
https://doi.org/10.1158/0008-5472.22366587.v1
Supplementary Figure 2 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Autor:
Michael W.N. Deininger, Brian J. Druker, Richard T. Silver, Jutta Deininger, Lisa Wood, Daniel Sherbenou, Marc Loriaux, Amie S. Corbin, Collin Elsea, Thomas G.P. Bumm
Supplementary Figure 2 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549c1e1b2be456f53fd9971e10aeb67a
https://doi.org/10.1158/0008-5472.22366599
https://doi.org/10.1158/0008-5472.22366599
Autor:
Karl J. Aichberger, Thomas Bumm, Michael W. Deininger, Brian J. Druker, Christopher J. Burns, Lisa Wood, Jutta Deininger, Emmanuelle Fantino, Marc M. Loriaux, Jeffrey W. Tyner
Publikováno v:
Blood. 115:5232-5240
Activating alleles of Janus kinase 2 (JAK2) such as JAK2V617F are central to the pathogenesis of myeloproliferative neoplasms (MPN), suggesting that small molecule inhibitors targeting JAK2 may be therapeutically useful. We have identified an aminopy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff860bd31074ddbac120c04c5a3b247
https://doi.org/10.1182/blood-2009-05-223727
https://doi.org/10.1182/blood-2009-05-223727
Autor:
Michael W. Deininger, Brian J. Druker, Jutta Deininger, Amy E. Hanlon Newell, Thomas Bumm, Susan B. Olson, Michael J. Mauro, Helen J. Lawce
Publikováno v:
Leukemia. 24:1525-1528
Letter to the Editor Clonal chromosomal abnormalities in Ph-negative cells (CCA/Ph-) have been identified in 3-15% of chronic myeloid leukemia (CML) patients with a partial or complete cytogenetic response (CCyR) to imatinib(1). Trisomy 8 and deletio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e5d7e4d8fad161d754052c0f9feaee
https://doi.org/10.1038/leu.2010.123
https://doi.org/10.1038/leu.2010.123